Andres Jesus Prada Rueda

Medico internista/ Gastroenterologo

[Joaquín Rodríguez | 🔎Endoscopia digestiva @joakirodriguez]

De un vistazo tienes todas las medidas para catalogar una lesión como sm1.

Fuente: Choi et al. Gastrointest Endosc Clin North Am. 2023

[Deepak Madhu @drdeepakmadhu]

✳️Seiwert types of EGJ carcinomas

✳️Useful for planning therapy

✳️Do meticulous exam and report accurately in your endoscopy report

🌟Distal end of palisade vessels is fairly accurate for GEJ
(Ref:https://t.co/abkcLHLDkZ)

Pic courtesy: https://t.co/9jnOz0fFiB

#GItwitter

[𝓢𝓱𝓪𝓭𝔂𝔂𝓾𝓼𝓲𝓯𝓜𝓓.𝓟𝓮𝓭𝓲𝓪𝓽𝓻𝓲𝓬𝓲𝓪𝓷 @DrShady_Yousif]

@drkeithsiau 💠Menetrier disease.
✅Dx:
1️⃣Aka hypoproteinemic hypertrophic gastropathy.
2️⃣Rare.
3️⃣Characterized by:
☑Giant mucosal folds in the proximal part of the stomach.
☑Diminished acid secretion.
☑Protein-losing state w/ hypoalbuminemia.
4️⃣Common in middle-aged men.
@IhabFathiSulima

[TheLiverDoc™ @theliverdoc]

Big news in the field of Hepatology

In 1980, Jurgen Ludwig and his colleagues at Mayo Clinic, identified a severe type of fatty liver disease in people who did not drink signficant amounts of alcohol. The disease was more common in women, most patients were obese and suffered from diabetes.

No journal would accept their findings and the new name they gave the disease at the time, for a very long time and the paper got rejected multiple times.

They called it NASH, short for non-alcoholic fatty liver disease - the most severe form of NAFLD - or non-alcoholic fatty liver disease. https://t.co/Og3vJ0WMfA

Forget the 3816 times the paper has been cited in medical literature since, but these two terms are so well-known and commonly used even among the non-medical community that it is argualby the most common-reason consultation in a liver outpatient clinic in the current era.

But the Hepatology societies thought the term was kind of stigmatizing - one, it centered around not using alcohol signficantly (alcoholic is not a nice term) and also impossed the term 'fatty' on patients, which was kind of "judgemental," with negativity.

Thus, a transparent and collaborative Nomenclature Development Initiative process was started in 2020 with multiple global hepatology and gastroenterology societies, patients and patient advocacy organizations, regulators and industry representatives. A total of 236 panellists from 56 countries participated in four online surveys and two hybrid meetings.

Yesterday, after almost 41 years in existence, the term NAFLD and NASH was retired.

The new kids on the block are here.
Please meet them.

It is no more fatty liver disease - it is steatotic liver disease or SLD

It is no more NAFLD - but MASLD or metabolic dysfunction-associated steatotic liver disease.
MASLD is identified when patients who have hepatic (liver) steatosis (at least 5% liver cells should have fat deposit) and have at least one of five cardiometabolic risk factors without signficant alcohol consumption.

Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for NASH.

But what if they have alcohol consumption which is inbetween insignficant consumption and signficiant consumption?
New category: MetALD - to describe those with MASLD who consume greater amounts of alcohol per week (140 g/week and 210 g/week for females and males respectively).

Those with no metabolic parameters and no known cause have "cryptogenic SLD."

This seminal paper and the rigorous scientific method which was followed to come to new terminologies is now available to read for free in the influential journal @HEP_Journal #LiverTwitter #MedTwitter

Read more on it here: https://t.co/HjyZw8KdVJ

[Jesús García-Cano @jgarciacano1]

Las coledocolitiasis de menos de 5 mm se suelen expulsar espontáneamente, aunque pueden causar colangitis o pancreatitis. Pasar un balón hinchado para extraerlas puede ser traumático para la Papila, a veces preferimos esfinterotomía y prótesis plástica.
https://t.co/pQZHgxgfHr

[Joaquín Rodríguez | 🔎Endoscopia digestiva @joakirodriguez]

🍄Hoy vamos a hablar de PÓLIPOS GÁSTRICOS🍄

6 tipos de lesiones que todo endoscopista debería saber reconocer.

Yo te hago un ULTRARRESUMEN.
Con que sepas esto, sabes mucho.
Pero mucho, mucho.
Si no te lo crees, mírate el hilo y verás.

[Antonio Caballero Mateos PhD @Dr_ACaballero_]

🌟Barcelona Clinic Liver Cancer Classification📝 ⏰BCLC 2022 Update

News:
🌀Extension of transplant cr outside Milan
🌀Downstaging🤏
🌀Laparoscopy for HCC resection🔪
🌀Atezo/Beva💊➡️1st line treatment in adv HCC

#GITwitter #livertwitter #MedEd #Medtwitter
@my_ueg @UEGJournal

[Joaquín Rodríguez | 🔎Endoscopia digestiva @joakirodriguez]

📢 Aviso:

Sólo para estudiosos de la endoscopia... Si no lo eres, no lo LEAS.

No creo que te haga falta.

Voy a contarte mi:

TOP 10 de REVISTAS PARA ENDOSCOPISTAS.

👨‍🎓Weeeaaa.

[Andres Jesus Prada Rueda @AndresJesusPra1]

@nicobeta713 ?

[Keith Siau @drkeithsiau]

Non malignant causes of raised CA19-9 #GITwitter

https://t.co/rk4Ov7oJYy

[Keith Siau @drkeithsiau]

Extrahepatic complications of hepatitis C infection #LiverTwitter #MedEd

(Via ⁦@NEJM⁩)

[Keith Siau @drkeithsiau]

Types of hiatus hernia #4KMedEd #GITwitter

(Via Shackleford's Surgery of the Alimentary Tract)

[Keith Siau @drkeithsiau]

Endoloop skill level: GODLIKE

https://t.co/VxapH43zr7

[UEGJ @UEGJournal]

📌 Rotor vs. Dubin-Johnson syndrome

- benign inheritable disorders of bilirubin metabolism manifested by conjugated hyperbilirubinemia

Review: https://t.co/XktupNl3w5
#GITwitter #LiverTwitter @my_ueg @WileyHealth

[Luis Valdovinos, MD, MSc, PhD(c) @drprapul]

Consenso sobre el diagnóstico de ERGE
https://t.co/tsu4Vby5aV

@ACTA_Gastro @gastromx @motilidad @chemaremes @JPandolfinoMD @valdovinosdma

[Keith Siau @drkeithsiau]

Subepithelial lesions of the GI tract - 🆕 ESGE guidelines on diagnosis, management and surveillance 🔦💡 #GITwitter

https://t.co/OBGyD7xi75

[Matthew Ho @MatthewHoMD]

Approach to diarrhea

Credit: @AmritKambojMD, @ytk_lau, @CPSolvers

[Andres Jesus Prada Rueda @AndresJesusPra1]

@EndoCollabcom B

[Keith Siau @drkeithsiau]

The 10 photos that should be taken during upper GI endoscopy (ESGE 2016 Guideline) #GITwitter #4KMedEd

[Keith Siau @drkeithsiau]

Guideline highlight 1️⃣ at ESGE Days: Management of lower GI bleeding (ESGE 2021 guideline)

🗓 Thursday 28th April, 0930
📍 Congress Hall
🗣 @iangralnek

https://t.co/PuMPXnAs9V